BACKGROUND:People with subclinical depressive symptoms are at increased risk of depressive disorder, little is known on the prevention of depressive disorder in this population. This study evaluates the long-term preventive effects of an effective depression treatment, the Coping with Depression (CWD) course. This paper describes the effect of the CWD course on the incidence of depressive episodes and depressive symptoms, and explores whether the initial level of symptoms and gender has differential intervention effects. METHODS:Participants (N=104) were adults with subclinical depressive symptoms, who were randomly assigned to either a preventive group course condition, the 'Coping with Depression' course, or to an assessment-and-advice-only control group condition. Follow-up results were measured 6 and 12 months after completion of the course. RESULTS: The CWD course showed to be effective in preventing depressive symptomatology but there was no evidence that the course prevented depressive disorder. 25% of the control group and 27.3% of the course group developed a depressive disorder within a year. Initial depressive symptomatology moderated the outcomes: only participants with low initial symptomatology appeared to benefit in the long term from course participation. CONCLUSIONS: The CWD course is effective as a treatment for subclinical depression. Preventive effects are restricted to participants with initially low depression levels. Therefore, this subgroup should be targeted in future depression-prevention practices and in future prevention studies.
RCT Entities:
BACKGROUND:People with subclinical depressive symptoms are at increased risk of depressive disorder, little is known on the prevention of depressive disorder in this population. This study evaluates the long-term preventive effects of an effective depression treatment, the Coping with Depression (CWD) course. This paper describes the effect of the CWD course on the incidence of depressive episodes and depressive symptoms, and explores whether the initial level of symptoms and gender has differential intervention effects. METHODS:Participants (N=104) were adults with subclinical depressive symptoms, who were randomly assigned to either a preventive group course condition, the 'Coping with Depression' course, or to an assessment-and-advice-only control group condition. Follow-up results were measured 6 and 12 months after completion of the course. RESULTS: The CWD course showed to be effective in preventing depressive symptomatology but there was no evidence that the course prevented depressive disorder. 25% of the control group and 27.3% of the course group developed a depressive disorder within a year. Initial depressive symptomatology moderated the outcomes: only participants with low initial symptomatology appeared to benefit in the long term from course participation. CONCLUSIONS: The CWD course is effective as a treatment for subclinical depression. Preventive effects are restricted to participants with initially low depression levels. Therefore, this subgroup should be targeted in future depression-prevention practices and in future prevention studies.
Authors: Mark Hyman Rapaport; Andrew A Nierenberg; Robert Howland; Christina Dording; Pamela J Schettler; David Mischoulon Journal: J Psychiatr Res Date: 2011-05-31 Impact factor: 4.791
Authors: Kim van Zoonen; Claudia Buntrock; David Daniel Ebert; Filip Smit; Charles F Reynolds; Aartjan T F Beekman; Pim Cuijpers Journal: Int J Epidemiol Date: 2014-04 Impact factor: 7.196
Authors: Lata K McGinn; Anna Van Meter; Ian Kronish; Jessica Gashin; Karen Burns; Natalie Kil; Thomas G McGinn Journal: Cognit Ther Res Date: 2019-02-12
Authors: Pernille Pedersen; Hans Jørgen Søgaard; Bjarne Frostholm Yde; Merete Labriola; Ellen A Nohr; Chris Jensen Journal: BMC Public Health Date: 2014-12-17 Impact factor: 3.295
Authors: Juan Ángel Bellón; Sonia Conejo-Cerón; Patricia Moreno-Peral; Michael King; Irwin Nazareth; Carlos Martín-Pérez; Carmen Fernández-Alonso; María Isabel Ballesta-Rodríguez; Anna Fernández; José María Aiarzaguena; Carmen Montón-Franco; Inmaculada Ibanez-Casas; Emiliano Rodríguez-Sánchez; Antonina Rodríguez-Bayón; Antoni Serrano-Blanco; María Cruz Gómez; Pilar LaFuente; María Del Mar Muñoz-García; Pilar Mínguez-Gonzalo; Luz Araujo; Diego Palao; Maite Espinosa-Cifuentes; Fernando Zubiaga; Desirée Navas-Campaña; Juan Mendive; Jose Manuel Aranda-Regules; Alberto Rodriguez-Morejón; Luis Salvador-Carulla; Juan de Dios Luna Journal: BMC Psychiatry Date: 2013-06-19 Impact factor: 3.630
Authors: Juan Á Bellón; Patricia Moreno-Peral; Berta Moreno-Küstner; Emma Motrico; José M Aiarzagüena; Anna Fernández; Carmen Fernández-Alonso; Carmen Montón-Franco; Antonina Rodríguez-Bayón; María Isabel Ballesta-Rodríguez; Ariadne Runte-Geidel; Ariadne Rüntel-Geidel; Janire Payo-Gordón; Antoni Serrano-Blanco; Bárbara Oliván-Blázquez; Luz Araujo; María del Mar Muñoz-García; Michael King; Irwin Nazareth; Manuel Amezcua Journal: PLoS One Date: 2014-03-19 Impact factor: 3.240